Targeting Ferroptosis Vulnerability in Synovial Sarcoma: Is It All About ME1?

Overview of attention for article published in Clinical Cancer Research, June 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

twitter: 45 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 2 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 68 X posts from 45 X users, with an upper bound of 173,221 followers.

RT @VivekSubbiah: @marklewismd Adding another metabolic pathway to your list to memorize this week. We added 🔥🔥to the figure 👉Understanding…

31 Mar 2023

Reply Repost Favourite

@marklewismd Adding another metabolic pathway to your list to memorize this week. We added 🔥🔥to the figure 👉Understanding metabolic therapeutic vulnerabilities are key to #PrecisionMedicine 👉"Targeting FERROPTOSIS Vulnerability in Synovial Sarcoma: Is it a

29 Mar 2023

Reply Repost Favourite

RT @VivekSubbiah: ⭐️What is in the pipeline beyond targeted & immunotherapies ? Read our editorial commentary in @AACR @CCR_AACR on metabo…

25 Mar 2023

Reply Repost Favourite

RT @VivekSubbiah: ⭐️What is in the pipeline beyond targeted & immunotherapies ? Read our editorial commentary in @AACR @CCR_AACR on metabo…

25 Mar 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 64 additional X posts.